Adial Pharmaceuticals, Inc. (ADIL)
NASDAQ: ADIL · Real-Time Price · USD
1.630
+0.050 (3.16%)
Apr 15, 2026, 3:17 PM EDT - Market open
ADIL's stock price has decreased by -90.84% in the past year and price targets may not have had time to catch up.
Adial Pharmaceuticals Analyst Ratings
Total Analysts
1
Consensus Rating
Strong Buy
Price Target
$37.50
Upside
+2,200.61%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Maxim Group | Maxim Group | Hold → Strong Buy Upgrades $38 | Hold → Strong Buy | Upgrades | $38 | +2,200.61% | Sep 30, 2025 |
| Rodman & Renshaw | Rodman & Renshaw | Strong Buy Initiates $200 | Strong Buy | Initiates | $200 | +12,169.94% | Nov 14, 2024 |
| Brookline Capital | Brookline Capital | Strong Buy Reiterates $3,750 | Strong Buy | Reiterates | $3,750 | +229,961.35% | Jul 11, 2023 |
| Maxim Group | Maxim Group | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Aug 17, 2022 |
| Brookline Capital | Brookline Capital | Strong Buy Initiates $7,500 | Strong Buy | Initiates | $7,500 | +460,022.70% | Oct 13, 2021 |
| Litchfield Hills | Litchfield Hills | Strong Buy Initiates $3,125 | Strong Buy | Initiates | $3,125 | +191,617.79% | Jun 29, 2021 |